Tailor-made therapy for smoking cessation by genetic analysis of smoking-related genes in Japanese
Tailor-made therapy for smoking cessation by genetic analysis of smoking-related genes in Japanese
批准号:
17590804
负责人:
NAKAMURA Hidetoshi
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006
中文摘要
我们检测了日本吸烟者(n=200)中CYP2A6^*4、^*7和^*9三种基因型与吸烟习惯的关系。^*1、^*4、^*7和^*9的频率分别为52、17、11、20%。当^*4、^*7、^*9为1个缺陷等位基因时,野生型、杂合子、纯合子突变率分别为26.0%、52.5%、21.5%。与杂合子或野生型相比,纯合子突变的受试者每天吸烟更少。日吸烟量以^*1/^*1最多,^*4/^*4最少,其余各型按等位基因缺陷数分布。已有研究表明,5-羟色胺转运体(5-HTT)启动子基因多态性与吸烟习惯和肺动脉重构有关。我们评估了该基因多态与吸烟行为、肺功能和胸部CT表现的关系。S/S 127例,S/L 61例,L/L 9例。与L组(S/L,L/L)相比,S组(S/S)每天吸烟和终生吸烟的次数多(P<0.05和P<0.01),吸烟持续时间长(P<0.01)。此外,S组的肺气肿改变明显多于L组(P=0.0 1),而%DL;提示5-HTT基因多态性与吸烟习惯有关,通过限制吸烟影响肺气肿的发生。尼古丁通过刺激多巴胺能神经元分泌多巴胺而导致烟草依赖。在多巴胺D2受体TaqI A1/A2多态分析中,A1/A29%、A1/A249%、A2/A242%。COPD患者与健康吸烟者的等位基因频率无明显差异。虽然吸烟习惯在A1/A1组间无差异,但A1/A1组的%VC和%FEV1显著高于A2/A2组(P<0.05)。D2A1/2多态与肺功能相关,与吸烟量无关。
英文摘要
We examined the relationship between the genotypes of CYP2A6^*4,^*7, and ^*9 and smoking habits in Japanese smokers (n=200). Frequencies of ^*1,^*4,^*7, and ^*9 were 52,17,11,20%. When ^*4,^*7, and ^*9 were regarded as one defective allele, percentages of wild type, heterozygote, homozygous mutant were 26.0,52.5,21.5%,respectively. Subjects with the homozygous mutant smoked fewer cigarettes/day compared with the heterozygote or wild type. Daily cigarette consumption was most in ^*1/^*1 and fewest in ^*4/^*4, and the other genotypes were located according to the number of defective alleles. It was reported that serotonin transporter (5-HTT) promoter polymorphism was associated with smoking habit and remodeling of pulmonary arteries. We evaluated the relationship between this polymorphism and smoking behaviors, pulmonary functions, and chest-CT findings. The numbers of subjects with each genotype were S/S 127,S/L 61, and L/L 9. Daily and lifelong cigarette consumption was more (p<0.05 and <0.01) and smoking duration was longer (p<0.01) in S group (S/S) compared with L group (S/L, L/L). In addition emphysematous changes were more (p=0.01) and %DL_<co> was lower (p<0.05) in S group than L group. These results suggested that the 5-HTT polymorphism was related to smoking habits affecting the development of emphysema through limiting cigarette consumption. Nicotine is responsible for tobacco dependence by stimulating dopaminergic neurons to secrete dopamine. In the analysis of dopamine D2 receptor TaqI A1/A2 polymorphism, the genotype frequencies were A1/A1 9%, A1/A2 49%, A2/A2 42%. There was no difference in the allele frequency between COPD patients and healthy smokers. Although smoking habits did not differ between the genotypes, %VC and %FEV1 were higher in A1/A1 group than A2/A2 group (p<0.05). The D2 A1/2 polymorphism was associated with pulmonary functions regardless of the amount of smoking.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
禁煙治療とCYPZA6遺伝子多型 ニコチン依存の〓解明と臨床応用について
戒烟治疗与CYPZA6基因多态性:尼古丁依赖的阐明及临床应用
DOI:
--
发表时间:
2006
期刊:
慶応医学 83・3
影响因子:
--
作者:
[仲村秀俊, 峰松直人, 石坂彰敏]
通讯作者:
石坂彰敏
Smoking cessation and CYP2A6 polymorphisms : mechanisms of nicotine dependence and clinical application
戒烟与CYP2A6多态性:尼古丁依赖机制及临床应用
DOI:
--
发表时间:
2006
期刊:
Keio Igaku 83-3
影响因子:
--
作者:
[Kanazawa H, et al., Hidetoshi Nakamura]
通讯作者:
Hidetoshi Nakamura
禁煙治療とCYP2A6遺伝子多型 ニコチン依存の程序解明と臨床応用について
戒烟治疗与CYP2A6基因多态性:阐明尼古丁依赖过程及临床应用
DOI:
--
发表时间:
2006
期刊:
慶應医学 83・3
影响因子:
--
作者:
[Akuta T, Zaki MH, Yoshitake J, Okamoto T, Akaike T, Ishimoto H, 仲村 秀俊]
通讯作者:
仲村 秀俊
DOI:
10.1183/09031936.06.00056305
发表时间:
2006-02-01
期刊:
EUROPEAN RESPIRATORY JOURNAL
影响因子:
24.3
作者:
[Minematsu, N, Nakamura, H, Ishizaka, A]
通讯作者:
Ishizaka, A
Limitation of cigarette consumption by CYP2A6^*4,^*7 and ^*9
CYP2A6^*4、^*7 和 ^*9 对香烟消费的限制
DOI:
--
发表时间:
2006
期刊:
European Respiratory Journal 27-2
影响因子:
--
作者:
[Sasaki N, Yamauchi K, Sato R, Masuda T, Sawai T, Inoue H., Naoto Minematsu]
通讯作者:
Naoto Minematsu
The Role of the European Union (EU) as an International Actor in the Tranforming Group of Seven (G7) System
-
批准号:22530167
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.25万
-
财政年份:2010
-
负责人:NAKAMURA Hidetoshi
-
依托单位:
NON-INVASIVE EXERCISE TEST FOR COPD PATIENTS BY FG VISION SENSOR
-
批准号:20590906
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2008
-
负责人:NAKAMURA Hidetoshi
-
依托单位:
Relationship between CC chemokine expression in the airways of severe asthmatics and steroid resistance
-
批准号:14570428
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2002
-
负责人:NAKAMURA Hidetoshi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Got2基因对浆细胞样树突状细胞功能的调控及其在系统性红斑狼疮疾病中的作用研究
-
批准号:82371801
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:周海波
-
依托单位:
Pik3r2基因突变在家族内侧颞叶癫痫中的作用及发病机制研究
-
批准号:82371454
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:郝勇
-
依托单位:
基于FCER1G基因介导免疫反应探讨迟发性聋与认知障碍相关性的机制研究
-
批准号:82371141
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈颖
-
依托单位:
发展基因编码的荧光探针揭示趋化因子CXCL10的时空动态及其调控机制
-
批准号:32371150
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:井淼
-
依托单位:
22q11.2染色体微重复影响TOP3B表达并导致腭裂发生的机制研究
-
批准号:82370906
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:代杰文
-
依托单位:
RET基因634位点不同氨基酸改变对甲状腺C细胞的影响与机制研究
-
批准号:82370790
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:叶蕾
-
依托单位:
lncGEI诱导湖羊卵巢颗粒细胞E2合成的分子机制
-
批准号:32372856
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:李隐侠
-
依托单位:
KMT2A基因突变通过DNMT3靶向调控GBP2导致神经发育障碍的机制研究
-
批准号:82371867
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王剑
-
依托单位:
综合医疗机构引入Gene-Xpert MTB/RIF技术早期发现传染性肺结核和耐药肺结核的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:
-
依托单位:
NFATc3转录调控MMP14介导少突胶质细胞瘤血管新生促肿瘤恶变的机制研究
-
批准号:32100563
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:齐琳
-
依托单位: